SCHEMBL20857042

SCHEMBL20857042

C=CC(=O)Nc1cc(C(=O)Nc2ccccc2)cc(C(F)(F)F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 4/20 0.62
LMNA P02545 1/20 0.59
TGM2 P21980 2/20 0.57
RHOC P08134 2/20 0.54
RHOA P61586 2/20 0.54
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54
KCNK3 O14649 1/20 0.53
RXFP1 Q9HBX9 3/20 0.52
HDAC3 O15379 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
TRPA1 O75762 1/20 0.51
CYP1A2 P05177 1/20 0.51
MAPT P10636 2/20 0.50
P2RX4 Q99571 1/20 0.48
P2RX7 Q99572 1/20 0.48
MEN1 O00255 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18763049 0.80 TGM2 (0.69) P2RX1LMNATGM2MAPTP2RX4
SCHEMBL23257556 0.80 TGM2 (0.50) P2RX1TGM2RHOCRHOATRPA1
SCHEMBL5037103 0.78 ALDH1A1 (0.68) LMNATGM2RAB9AMAPTMEN1
SCHEMBL15541487 0.78 TGM2 (0.61) P2RX1LMNATGM2MAPTHTT
SCHEMBL27568768 0.77 P2RX1 (0.76) P2RX1LMNARHOCRHOARAB9A
SCHEMBL23447713 0.77 P2RX1 (1.00) P2RX1LMNARAB9ANPC1KCNK3
SCHEMBL22387581 0.77 LMNA (0.67) P2RX1LMNARHOCRHOARAB9A
SCHEMBL30211836 0.77 TGM2 (0.96) LMNATGM2CYP1A2
SCHEMBL16895199 0.76 TGM2 (0.52) P2RX1TGM2TRPA1CYP1A2MAPT
SCHEMBL4746373 0.76 ALOX5 (0.71) LMNATGM2RAB9ANPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
EP-3688472-A1 CONJUGATED PROTEINS AND USES THEREOF The Scripps Research Institute (US) 2020-08-05 EP disclosed
WO-2019067741-A1 CONJUGATED PROTEINS AND USES THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2019-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF KEAP1, GSTK1, GSTM2 P2RX1 4676/4885LMNA 2810/4885TGM2 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.